Skip to content

Start Here
Research
Latest
Stock Market
Market Education
Capital Markets
Federal Reserve & Rates
About
Contact

vktx

Viking Therapeutics Prices Upsized $500M Dual Capital Raise

September 24, 2026 by Bruno

AI-generated editorial image: Pharmaceutical research laboratory workstation with testing vials and analytical equipment under natural daylight.

Viking Therapeutics priced an upsized $500M capital raise, pairing $275M in common stock at $35 and $225M in 2% convertible senior notes due 2032.

Categories IPO & Public Offerings, Stock Market Tags capital markets, convertible notes, GLP-1, stock offering, viking therapeutics, vktx

Search

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

Start Here
Market Education
Stock Market
Capital Markets
Federal Reserve & Rates

Recent Posts

Akamai Lands $11.6B Anthropic Cloud Deal and 5% Warrant
Open Market Operations: How the Fed and the Desk Steer Rates
McGraw Hill Launches $500M Notes in $1.33B Debt Refinancing
Darden Q1 Sales Hit $3.2B as LongHorn Outpaces Olive Garden
Shelf Registration Explained: Form S-3, Rule 415, and Takedowns

About · Editorial Policy · Corrections · Disclaimer · Privacy · Contact

© 2026 Equity Capital Market • Built with GeneratePress